5 CoA Checks to Verify Peptide Purity Before Use

Peptide purity CoA title card

For exploratory screening, crude or peptide around the 70 to 80% purity range is often adequate. Peptide arrays and non-quantitative ELISA work typically call for purity generally in the mid-70s to mid-80s percentage range, epitope mapping and many bioassays need mid-80s to mid-90s, and quantitative bioassays or in vivo pharmacology require high purities, with analytical standards and NMR work demanding purities near or above 98%. Whatever the application, always confirm the lot-specific Certificate of Analysis and the methods behind it before you run the assay.

TL;DR:

  • Crude or approximately 70 to 80% purity peptides are sufficient for exploratory screening, while higher purities are required for quantitative bioassays and pharmacology.
  • Purity should be verified with detailed lot-specific Certificates of Analysis, including chromatograms and mass spectra, especially before high-stakes experiments.
  • Impurities like counterions, residual solvents, water, and inorganic residues can inflate purity percentages and must be considered when calculating doses.
  • Storage, handling, and reconstitution conditions impact peptide stability and purity, with lyophilized peptides maintaining quality longer than solutions.
  • Requesting complete, unredacted CoAs and comparing lots helps prevent reproducibility issues and ensures data integrity.
Purity X Peptides
Choose Peptides With Clearer Research Information
Explore peptides and research chemicals with detailed research information, purity levels, and transparency for informed laboratory studies.
Visit Purity X Peptides

Table of Contents

Choosing a purity level is really a question of what the data needs to support. A screening assay that tolerates background noise does not need the same rigor as a dose-response curve feeding a publication.

A practical mapping researchers can use:

  • Screening and sequence optimization: crude or approximately 70 to 80% HPLC purity is usually sufficient.
  • Peptide arrays and routine ELISA coating: 75 to 85% is a common working range.
  • Western blot blocking and non-quantitative assays: 80 to 90% typically performs well.
  • Epitope mapping, phosphorylation assays, and many in vitro bioassays: 85 to 95% gives a reasonable margin.
  • Quantitative kinetics, receptor-ligand binding, in vivo pharmacology, and NMR: 95 to 98% or higher is the expected baseline.

These ranges and their application mapping reflect common grading conventions described in peptide synthesis guidance, where purity is treated as a spectrum rather than a pass or fail threshold. Academic core facilities echo a similar four-tier structure in their own service descriptions, tying purity grade to intended use rather than defaulting everyone to the highest tier.

Cost and synthesis difficulty scale with purity, and yield drops as purification gets more aggressive. Sequences with long hydrophobic stretches or multiple cysteines are harder to purify cleanly and often need extra purification steps to remove deletion sequences or aggregation products, which pushes cost higher for the same nominal purity target.

Pro Tip: When switching suppliers or receiving a new lot, run a small pilot assay before committing a full experimental series. It costs less than discovering an activity shift halfway through a dose-response curve.

What peptide purity actually measures

“Purity” is not one number. Chromatographic purity, usually reported as HPLC area percent, measures the proportion of UV or detector signal attributable to the main peak relative to total signal. It is useful for spotting impurity profiles but cannot confirm identity on its own, since co-eluting impurities can hide under the main peak and inflate the apparent value.

Mass-balance purity takes a different approach: it accounts for everything that is not peptide, then reports what remains. This distinction matters when comparing an “as is” value to an anhydrous, counterion-free basis, since the two numbers can differ meaningfully for the same vial.

Mass that is not peptide commonly comes from:

  • Counterions such as trifluoroacetate (TFA) or acetate, retained from synthesis and purification.
  • Residual solvents left over from synthesis or lyophilization.
  • Inorganic residue from buffers or reagents used during purification.
  • Water content, which can be substantial in lyophilized powders.

The USP’s reference standard methodology subtracts these components from total mass to assign an absolute peptide content, which is the basis for reliable dose calculations in quantitative work.

How to test and verify peptide purity

No single method answers every question a researcher needs answered, which is why orthogonal testing exists: chromatographic separation for profile, high-resolution mass spectrometry for identity, and quantitative NMR or mass-balance calculation for absolute content when dosing accuracy matters.

Before relying on a lot for sensitive work, request:

  1. Method parameters behind the HPLC run, including column type, gradient, and detection wavelength.
  2. The full chromatogram, not a cropped image or a summary number.
  3. Retention time comparison against a reference standard where available.
  4. Mass spectra confirming molecular identity.
  5. Residual solvent and water content results, tied to the same lot number as the CoA.

Third-party testing earns its cost for high-impact in vivo or GLP-adjacent work, where an undetected deviation could invalidate months of data. In-house quick checks, by contrast, are reasonable for routine screening where the stakes of a minor impurity are lower.

On arrival, a simple quality-control sequence helps catch problems early:

  1. Visual inspection of the lyophilized powder or solution for discoloration or clumping.
  2. A quick mass spec identity check against the expected molecular weight.
  3. An HPLC comparison against the supplier’s chromatogram.
  4. Logging the CoA and lot number against the experimental record before first use.

Pro Tip: Ask for unredacted chromatograms and method SOPs for any lot feeding a quantitative or translational experiment. A summary percentage without supporting data is not verification.

Reading a Certificate of Analysis and managing lot variability

A CoA is only as useful as the detail it contains. At minimum, look for the lot number, peptide identity confirmed by mass spectrometry, the HPLC method and resulting area percent, an actual chromatogram image, counterion identity, water content, residual solvent results, the assay value in milligrams of peptide per vial, and the analyst and date of testing. Any deviation or out-of-spec note should be stated explicitly, not omitted.

Certificate of Analysis verification fields

Comparing CoAs across lots is where batch-to-batch problems surface. When that happens, contact the supplier for clarification, request reanalysis, quarantine the lot until resolved, or send a sample for independent third-party testing.

Our Certificate of Analysis page reflects this same level of detail for every batch we list, which gives researchers a working example of what a complete CoA should contain.

Good recordkeeping closes the loop: store CoA PDFs alongside experimental records, link lot numbers directly to the data they produced, and use the assay-derived peptide content, not the nominal vial size, when calculating doses.

Standards and regulatory context worth knowing

Compendial and regulatory guidance give researchers a shared reference point rather than relying on supplier claims alone.

  • USP reference standards and analytical reference materials support value assignment and impurity profiling through orthogonal testing, as described in USP’s peptide reference standard resources.
  • FDA guidance on peptide drug products calls for identifying and characterizing impurities at levels of 0.10% or greater and sets qualification expectations for impurities and aggregates, as outlined in the agency’s peptide impurity guidance.
  • For researchers whose work may eventually feed translational or regulatory submissions, adopting that same 0.10% identification threshold as an internal QC trigger is a reasonable, conservative practice even outside a formal regulatory pathway.

Perspective from Purity X Peptides: how we document purity

We offer compounds across categories like metabolic and longevity research, including GLP-3, GHK-Cu, and glutathione formulations, each paired with documentation describing its intended research use. Every compound we list carries detailed information on formulation and purity so researchers can judge fit before ordering. Our CoA page gives direct access to lot-specific chromatograms and assay data, which we recommend checking against the lot number on your shipment before any experiment begins.

Storage and handling after receipt

Purity on paper does not survive poor handling. Lyophilized peptides are generally more stable than reconstituted solutions, so storing vials lyophilized at the temperature the supplier specifies, typically frozen, preserves purity far longer than keeping them at room temperature or refrigerated.

Once reconstituted, most peptides degrade faster, through hydrolysis, oxidation, or aggregation, depending on the sequence. Aliquoting a reconstituted peptide into single-use volumes and refreezing unused portions avoids repeated freeze-thaw cycles, which is one of the more common sources of avoidable purity loss in a working lab.

Technician aliquoting peptide vials into freezer rack

Exposure to light, humidity, and oxygen all accelerate degradation for sensitive sequences, particularly those containing methionine, cysteine, or tryptophan residues. Using amber vials or foil wrapping, along with desiccant storage for lyophilized powder, reduces that exposure.

Every reconstitution and freeze-thaw event is also a point where contamination can enter, so sterile technique and clean diluents matter as much for maintaining purity as the original synthesis did. Tracking each vial’s handling history alongside its CoA gives a fuller picture when a lot behaves unexpectedly weeks after arrival, since degradation during storage can look identical to a manufacturing issue if the two are not distinguished.

Our take on picking and verifying peptide purity

The biggest mistake we see is treating purity as a single number to maximize rather than a specification to match against the actual experiment. A 98% peptide is not automatically a better choice for a screening assay than an 80% one. It is often just a more expensive one, with no measurable benefit to the result.

The more overlooked risk sits in verification, not grade. A high purity percentage on a label means little if the underlying chromatogram, mass spec identity, and lot number are not available for inspection. Researchers who skip that step are trusting a number rather than checking it.

If you take one habit from this article, make it this: request the full CoA, including the chromatogram, before the peptide arrives, and compare it against the prior lot if you have used the supplier before. That single step catches more reproducibility problems than switching to a higher nominal purity ever will.

— Purity X Peptides

Where to start if you need verified high-purity peptides

If you are selecting a compound for metabolic, recovery, or aesthetic research, our GLP-3 ® 30mg, KPV 10mg, and Glutathione 1500mg listings each include documentation suited to lab verification before you commit a batch to an experiment.

GLP-3 (R) 30mg

Our Longevity and Metabolic collections are reasonable starting points if you are comparing options across a research program rather than a single compound. Every product we list is intended strictly for laboratory research use, and we recommend checking the lot-specific CoA against your own verification checklist before any experiment begins.

FAQ

What is a good purity for peptides?

A good purity depends on the experiment. Screening work is often fine at 70 to 85%, while quantitative bioassays, in vivo pharmacology, and NMR typically call for 95 to 98% or higher, as outlined in common peptide purity grading conventions.

What are high purity peptides?

High purity peptides generally refer to material at 95% or above by HPLC area percent, a grade typically reserved for quantitative assays, in vivo studies, and analytical reference work. Lower grades remain appropriate for screening and non-quantitative applications where absolute precision matters less.

Can peptides be 100% pure?

Reported values close to 98% represent the practical ceiling achievable with current purification methods.

How to test BPC-157 for purity?

Testing synthetic peptides relies on an orthogonal approach: HPLC or UHPLC for chromatographic profile, high-resolution mass spectrometry for identity confirmation, and mass-balance or qNMR calculation when absolute content is required for dosing. Reviewing the lot-specific chromatogram and mass spectra against the Certificate of Analysis is the most direct way to confirm a given vial matches its stated purity.

Sources